Skip to content

Effectiveness and safety of Swarna makshika bhasma in Erectile Dysfunction

EFFICACY AND SAFETY OF SWARNA MAKSHIKA BHASMA IN ERECTILE DYSFUNCTION A RANDOMIZED CONTROLLED CLINICAL TRIAL - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101325
Enrollment
22
Registered
2026-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N529- Male erectile dysfunction, unspecified

Interventions

None listed

Sponsors

Dr Swati Shivanand Rane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients fulfilling the diagnostic criteria of IIEF 15 2 Sexually Active Males 3 Erectile dysfunction associated with or without Premature ejaculation 4 Erectile Dysfunction associated with or without infertility 5 Erectile Dysfunction Secondary to with or without diabeties mellitus 6 Patients with classical symptoms of klaibya 7 willing and able to give informed consent

Exclusion criteria

Exclusion criteria: 1 known cases of uncontrolled hypertension 2 known cases of other major systemic disorders which interfere with the treatment 3 subjects having genital anamolies 4 diagnosed cases of peyronies disease or other anatomical defects 5 known cases of congenital genital anamolies 6 known cases of sexually transmitted diseases 7 participation of patients in other studies or receipt of other investigational drugs within 15 days prior to baseline 8 patients taking concomittent medications that may interfere with the study results as per investigators opinion

Design outcomes

Primary

MeasureTime frame
Improvement in Erectile Function assessed by change in International Index of erectile Function score from baseline to end of treatmentTimepoint: Day 16 Day 46

Secondary

MeasureTime frame
Improvement in symptoms of klaibya enhancement of libido & over all sexual satisfaction & evaluation of the safety & tolerability of swarna makshika bhasmaTimepoint: Day 16 Day 46

Countries

India

Contacts

Public ContactDr Kashavva Hiremath

KAHERs Shri BMK Ayurveda Mahavidyalaya Post Graduate Studies and Research Centre

kvhiremath.kaher@kleayurworld.edu.in9448945687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026